Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Pneumococcal vaccine ====== ===== Indications ===== ==== Posttraumatic meningitis treatment ==== In [[posttraumatic meningitis treatment]]: for adults (age ≥ 19 years) with [[cerebrospinal fluid fistula]] who have not received any pneumococcal [[vaccine]]s, or for those with unknown vaccination history, the CDC recommends 1 dose of PCV13 and 1 or 2 doses of PPSV23 as follows ((CDC. Pneumococcal vaccine timing for adults. 2015. https://www.cdc.gov/vaccines/vpd/pneumo/downloads/pneumo-vaccine-timing.pdf)) (Note: these [[recommendation]]s are specific for adults with [[CSF leak]]s and differ from general vaccination recommendations): ● 1 dose of pneumococcal conjugate vaccine (pneumococcal PCV13) (e.g. Prevnar 13) ● 1 dose of pneumococcal polysaccharide vaccine (PPSV23) (e.g. Pneumovax, Merck) at least 8 weeks later ● for patients ≥ 65 years: PPSV23 ≥ 8 weeks after PCV13 and ≥ 5 years after any PPSV23 at < 65 years ===== Skull base fracture ===== In [[skull base fracture]], if there is a [[CSF leak]], [[pneumococcal vaccine]] is recommended for adults age 2–65 years ((Immunize.org. Pneumococcal Vaccines (PCV13 and PPSV23).2017.http://www.immunize.org/askexperts/experts_pneumococcal_vaccines.asp)). pneumococcal_vaccine.txt Last modified: 2024/06/07 02:59by 127.0.0.1